Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios

Abstract Background Prostate cancer screening incurs a high risk of overdiagnosis and overtreatment. An organized and age‐targeted screening strategy may reduce the associated harms while retaining or enhancing the benefits. Methods Using a micro‐simulation analysis (MISCAN) model, we assessed the h...

Full description

Saved in:
Bibliographic Details
Main Authors: Abraham M. Getaneh, Eveline A. M. Heijnsdijk, Monique J. Roobol, Harry J. deKoning
Format: Artigo
Language:Inglês
Published: Wiley 2020-10-01
Series:Cancer Medicine
Subjects:
harms and benefits; cost‐effectiveness
micro‐simulation
prostate cancer
prostate‐specific antigen (PSA) screening
Online Access:https://doi.org/10.1002/cam4.3395
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items